Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Needs Acquisitions: Here's The List
Seeking Alpha
Tuesday, July 23, 2013 - 12:07pm
tags:
Merck, M&A, Celgene, Dendreon, Endocyte, Immunomedics, Isis Pharmaceuticals, Vical, ONYX Pharmaceuticals
Ironwood Pharma 2Q loss widens, revenue slides
Yahoo/AP
Tuesday, July 23, 2013 - 11:56am
tags:
earnings, Ironwood Pharmaceuticals
XenoPort announce inclusion of Horizant in new treatment guidelines
Yahoo/Fly on the Wall
Tuesday, July 23, 2013 - 11:20am
tags:
XenoPort, Horizant
Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease
Seeking Alpha
Tuesday, July 23, 2013 - 11:19am
tags:
Athersys, inflammatory bowel disease, clinical trials, MultiStem, stem cells
Earnings Increase Expected for Celgene (CELG)
Forbes
Tuesday, July 23, 2013 - 11:18am
tags:
earnings, Celgene
Array Seeks Asthma Drug Partner Following Mid-Stage Study Results
TheStreet.com
Tuesday, July 23, 2013 - 11:17am
tags:
asthma, Array Biopharma, Merck, Amgen, ARRY-502
Novo Nordisk: A Pure Play In The Large And Lucrative Diabetes Care Sector
Seeking Alpha
Tuesday, July 23, 2013 - 11:14am
tags:
Novo Nordisk, diabetes, MannKind, Merck
Anatomy of an Earnings Jump: Cubist Pharmaceuticals
Motley Fool
Tuesday, July 23, 2013 - 11:13am
tags:
earnings, Cubist Pharmaceuticals
Forest Laboratories Earnings: Here’s Why Shares are Up Now
Wall St. Cheat Sheet
Tuesday, July 23, 2013 - 11:11am
tags:
earnings, Forest Labs
Teva developing new medicines to treat brain disorders -CEO
Reuters
Tuesday, July 23, 2013 - 11:11am
tags:
Teva, Jeremy Levin, Alzheimer's disease, ALS, Huntington's disease, Parkinson's Disease
[video] Onyx Prepares for Multiple Bids After Amgen Snub
Bloomberg
Tuesday, July 23, 2013 - 11:00am
tags:
ONYX Pharmaceuticals, Amgen, M&A, AstraZeneca, Pfizer, Novartis
Will GlaxoSmithKline Face A Ban In China? Well, No Need To Be Bearish Even If It Does
Seeking Alpha
Tuesday, July 23, 2013 - 10:59am
tags:
GSK, China
Glaxo fallout in China bribe scandal could be minimal, analysts say
Marketwatch
Monday, July 22, 2013 - 6:11pm
tags:
GSK, China
The Diabetes Pipeline With a Clog
Motley Fool
Monday, July 22, 2013 - 6:02pm
tags:
diabetes, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, JNJ, SGLT2 inhibitor, Forxiga, Invokana, empagliflozin
AstraZeneca, Pfizer among possible bidders for Onynx, Bloomberg reports
Yahoo/Fly on the Wall
Monday, July 22, 2013 - 5:59pm
tags:
Pfizer, AstraZeneca, ONYX Pharmaceuticals, M&A
Keryx Biopharmaceuticals' Zerenex Likely To Receive FDA Approval
Seeking Alpha
Monday, July 22, 2013 - 5:58pm
tags:
Keryx, FDA, Zerenex, Sanofi, Shire, hyperphosphatemia
Tell The Kids: 10,000 Jobs At Pharma Companies
Forbes
Monday, July 22, 2013 - 5:56pm
tags:
hirings
Mallinckrodt Pays $3.5M To Settle Kickback Charges
Pharmalot
Monday, July 22, 2013 - 5:54pm
tags:
Mallinckrodt, kickbacks, whistleblower lawsuits
A Small Biotech With Breakthrough Potential In Cancer Treatment
Seeking Alpha
Monday, July 22, 2013 - 11:35am
tags:
DCVax, Northwest Biotherapeutics, prostate cancer
ChinaGate: Glaxo Issues A Mea Culpa And AstraZeneca Is Questioned
Pharmalot
Monday, July 22, 2013 - 11:29am
tags:
GSK, China, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.